Functional gadolinium-based nanoscale systems for cancer theranostics.

Area of Science:

• Nanomedicine
• Biotechnology
• Materials Science

Background:

• Cancer theranostics combines imaging and treatment for improved patient outcomes.
• Theranostic agents require biocompatibility, tumor specificity, and therapeutic efficacy.
• Gadolinium (Gd)-based nanomaterials are emerging as versatile platforms for cancer theranostics.

Purpose of the Study:

• To review recent advancements in Gd-based nanomaterials for cancer theranostics.
• To highlight the design and synthesis strategies for effective theranostic agents.
• To discuss the future perspectives of Gd nanomaterial-based cancer theranostics.

Main Methods:

• Literature review of recent research on Gd-based nanomaterials for cancer theranostics.
• Analysis of studies focusing on the integration of imaging and therapeutic functionalities.
• Synthesis and characterization of Gd-based theranostic agents.

Main Results:

• Gd-based nanomaterials can effectively combine therapeutic agents with Gd for enhanced efficacy.
• Incorporation of Gd ions, chelates, or probes allows for real-time monitoring via imaging.
• These nanomaterials demonstrate potential for tumor-specific targeting and treatment.

Conclusions:

• Gd-based nanomaterials represent a promising strategy for advancing cancer theranostics.
• Further research is needed to optimize their design for clinical translation.
• These agents offer a pathway to more efficient and safer cancer treatment with integrated monitoring.